Abstract:Abstract KRAB containing zinc finger proteins form the largest class of mammalian transcription factors. However, the physiological or pathological functions of the majority of them are unknown. Here, we established ZFP14 as a p53 target gene that is induced upon genotoxic stress in a p53-dependent manner. To determine the function of ZFP14 in mouse and human cancer cell lines, we generated ZFP14-KO cells that showed increased senescence as well as reduced cell growth and migration. Moreover, we showed that ZFP14 negatively regulates p53, which was the cause of reduced oncogenic properties in ZFP14-KO cancer cells. Mechanistically, we found that ZFP14 modulates p53 protein stability by associating with and possibly enhancing MDM2/p53 complex integrity through its zinc finger domains. Interestingly, we found that lower expression of ZFP14 correlates with poor patient survival in multiple human cancers. Notably, in a similar fashion, mice deficient in ZFP14 were susceptible to spontaneous tumor formation, developed other abnormalities such as systemic inflammation and liver steatosis, which led to their shorter lifespan. Finally, we showed that ZFP14 regulates the expression of the HOXA gene cluster in mouse and humans, which we propose as a possible mechanism by which ZFP14 regulates tumorigenesis. Our findings suggest that ZFP14 is an important regulator of p53 and HOXA genes during inflammation and tumorigenesis. Citation Format: Shakur Mohibi, Jin Zhang, Mingyi Chen, Xinbin Chen. ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 830.

Genetic Mechanisms of Tumor Suppression by the Human p53 Gene

Abstract 2988: Loss of Rbm38 Cooperates with Mutant P53 to Promote Lymphomagenesis Through Downregulation of Pten

Modeling the Etiology of p53-mutated Cancer Cells

Gain of Function of P53 Cancer Mutants in Disrupting Critical DNA Damage Response Pathways

High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

Mutant P53 in Cancer: Accumulation, Gain-of-Function, and Therapy.

Gain-of-function mutant p53 in cancer progression and therapy

[Advances on Mutant P53 Research].

Mutant p53 in Cancer Progression and Targeted Therapies

Chromosome Stability, in the Absence of Apoptosis, is Critical for Suppression of Tumorigenesis in Trp53 Mutant Mice

Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression

Generation and Characterization of P53 Mutant Mice.

p53: 800 million years of evolution and 40 years of discovery

TP53: the unluckiest of genes?

Mutant p53 as a guardian of the cancer cell

Inactivation of p53 tumor suppressor gene acts synergistically with c- neu oncogene in salivary gland tumorigenesis

p53 signaling in cancer progression and therapy

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

The Development of P53-Targeted Therapies for Human Cancers

Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting